Relafen 750 mg, a noncopyrightal anti-inflammatory drug (NSAID), displays significant biochemical characteristics that contribute to its therapeutic efficacy. A comprehensive analysis of these properties reveals valuable insights into the mechanism of action and potential clinical implications. The drug's primary focus is the inhibition of cyclooxy